{"id":"https://openalex.org/W4415940906","doi":"https://doi.org/10.1016/j.annonc.2025.08.2573","title":"1949P Sacituzumab tirumotecan (sac-TMT) + pembrolizumab (pembro) for treatment-na\u00efve advanced PD-L1-positive NSCLC: Results from the phase II MK-2870-003/SKB264-II-04 study","display_name":"1949P Sacituzumab tirumotecan (sac-TMT) + pembrolizumab (pembro) for treatment-na\u00efve advanced PD-L1-positive NSCLC: Results from the phase II MK-2870-003/SKB264-II-04 study","alternate_titles":[],"publication_year":2025,"publication_date":"2025-09-01","ids":{"openalex":"https://openalex.org/W4415940906","doi":"https://doi.org/10.1016/j.annonc.2025.08.2573"},"language":"en","primary_location":{"id":"doi:10.1016/j.annonc.2025.08.2573","doi":"https://doi.org/10.1016/j.annonc.2025.08.2573","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2025.08.2573","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4415940906"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.annonc.2025.08.2573","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111299490","display_name":"W.F. Fang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146711","display_name":"Sun Yat-sen University Cancer Center","ror":"https://ror.org/0400g8r85","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210146711"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W.F. Fang","raw_affiliation_strings":["Internal Department, Sun Yat-sen University Cancer Center, Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Department, Sun Yat-sen University Cancer Center, Guangzhou, China","institution_ids":["https://openalex.org/I4210146711"]}]},{"author_position":"middle","author":{"id":null,"display_name":"W. Yao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118556","display_name":"Sichuan Cancer Hospital","ror":"https://ror.org/029wq9x81","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210118556"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W. Yao","raw_affiliation_strings":["Medical Oncology Department, Sichuan Cancer Hospital, Chengdu, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Sichuan Cancer Hospital, Chengdu, China","institution_ids":["https://openalex.org/I4210118556"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006455181","display_name":"Xiujuan Qu","orcid":"https://orcid.org/0009-0005-9366-2314","observed_orcids":["https://orcid.org/0009-0005-9366-2314"]},"institutions":[{"id":"https://openalex.org/I4210140515","display_name":"First Hospital of China Medical University","ror":"https://ror.org/04wjghj95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140515"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"X. Qu","raw_affiliation_strings":["Oncology Department, The First Hospital of China Medical University, Shenyang City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, The First Hospital of China Medical University, Shenyang City, China","institution_ids":["https://openalex.org/I4210140515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101998973","display_name":"XingYa Li","orcid":"https://orcid.org/0000-0001-9121-6613","observed_orcids":["https://orcid.org/0000-0001-9121-6613"]},"institutions":[{"id":"https://openalex.org/I4210156804","display_name":"First Affiliated Hospital of Zhengzhou University","ror":"https://ror.org/056swr059","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156804"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"X. Li","raw_affiliation_strings":["Oncology Department II, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department II, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China","institution_ids":["https://openalex.org/I4210156804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057704753","display_name":"Ying Cheng","orcid":"https://orcid.org/0000-0001-9908-597X","observed_orcids":["https://orcid.org/0000-0001-9908-597X"]},"institutions":[{"id":"https://openalex.org/I4210098607","display_name":"Jilin Province Tumor Hospital","ror":"https://ror.org/00vgek070","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098607"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Y. Cheng","raw_affiliation_strings":["Oncology Department, Jilin Cancer Hospital, Changchun City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, Jilin Cancer Hospital, Changchun City, China","institution_ids":["https://openalex.org/I4210098607"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042358323","display_name":"Yang Yu","orcid":"https://orcid.org/0000-0002-2409-3681","observed_orcids":["https://orcid.org/0000-0002-2409-3681"]},"institutions":[{"id":"https://openalex.org/I4210103956","display_name":"Third Affiliated Hospital of Harbin Medical University","ror":"https://ror.org/01f77gp95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103956"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Y. Yu","raw_affiliation_strings":["Oncology Department, Harbin Medical University Cancer Hospital, Harbin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, Harbin Medical University Cancer Hospital, Harbin, China","institution_ids":["https://openalex.org/I4210103956"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100697277","display_name":"Yizhen Wang","orcid":"https://orcid.org/0000-0002-3908-7102","observed_orcids":["https://orcid.org/0000-0002-3908-7102","https://orcid.org/0000-0003-4364-4271"]},"institutions":[{"id":"https://openalex.org/I4210089761","display_name":"West China Hospital of Sichuan University","ror":"https://ror.org/007mrxy13","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210089761"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Y. Wang","raw_affiliation_strings":["Biotherapeutic Research Center, West China Hospital of Sichuan University, Chengdu, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biotherapeutic Research Center, West China Hospital of Sichuan University, Chengdu, China","institution_ids":["https://openalex.org/I4210089761"]}]},{"author_position":"middle","author":{"id":null,"display_name":"W. Zhuang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148548","display_name":"Fujian Provincial Cancer Hospital","ror":"https://ror.org/058ms9w43","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210148548"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W. Zhuang","raw_affiliation_strings":["Thoracic Oncology Department, Fujian Cancer Hospital, Fuzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology Department, Fujian Cancer Hospital, Fuzhou City, China","institution_ids":["https://openalex.org/I4210148548"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021139793","display_name":"Baohui Han","orcid":"https://orcid.org/0000-0002-3950-3030","observed_orcids":["https://orcid.org/0000-0002-3950-3030"]},"institutions":[{"id":"https://openalex.org/I2802608112","display_name":"Shanghai Chest Hospital","ror":"https://ror.org/03fjc3817","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802608112"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B. Han","raw_affiliation_strings":["Respiratory Department, Shanghai Chest Hospital, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory Department, Shanghai Chest Hospital, Shanghai, China","institution_ids":["https://openalex.org/I2802608112"]}]},{"author_position":"middle","author":{"id":null,"display_name":"P. Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802573037","display_name":"Tianjin Medical University Cancer Institute and Hospital","ror":"https://ror.org/0152hn881","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802573037"]},{"id":"https://openalex.org/I5740404","display_name":"Tianjin Medical University","ror":"https://ror.org/02mh8wx89","country_code":"CN","type":"education","lineage":["https://openalex.org/I5740404"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. Chen","raw_affiliation_strings":["Pulmonary Oncology Department, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary Oncology Department, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China","institution_ids":["https://openalex.org/I2802573037","https://openalex.org/I5740404"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Y. Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115624","display_name":"Hunan Cancer Hospital","ror":"https://ror.org/025020z88","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210115624"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Y. Zhang","raw_affiliation_strings":["Department of Pulmonary and Gastroenterology, Hunan Cancer Hospital, Changsha City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pulmonary and Gastroenterology, Hunan Cancer Hospital, Changsha City, China","institution_ids":["https://openalex.org/I4210115624"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087483866","display_name":"Jingyi Zhou","orcid":"https://orcid.org/0009-0006-5560-0910","observed_orcids":["https://orcid.org/0009-0006-5560-0910","https://orcid.org/0009-0003-3892-5869"]},"institutions":[{"id":"https://openalex.org/I4210166576","display_name":"First Affiliated Hospital Zhejiang University","ror":"https://ror.org/05m1p5x56","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210166576"]},{"id":"https://openalex.org/I76130692","display_name":"Zhejiang University","ror":"https://ror.org/00a2xv884","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Zhou","raw_affiliation_strings":["Respiratory Department, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory Department, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China","institution_ids":["https://openalex.org/I4210166576","https://openalex.org/I76130692"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029786366","display_name":"Jun Zhao","orcid":"https://orcid.org/0000-0002-7739-6715","observed_orcids":["https://orcid.org/0000-0002-7739-6715","https://orcid.org/0009-0000-8435-9894"]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Zhao","raw_affiliation_strings":["Department One of Thoracic Oncology, Beijing Cancer Hospital, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department One of Thoracic Oncology, Beijing Cancer Hospital, Beijing, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Chen","raw_affiliation_strings":["Medical Oncology, Merck & Co., Inc., North Wales, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Merck & Co., Inc., North Wales, United States of America","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Q. Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Q. Chen","raw_affiliation_strings":["Medical Oncology, Merck & Co., Inc., Rahway, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Merck & Co., Inc., Rahway, United States of America","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074943987","display_name":"GM Blumenthal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. Blumenthal","raw_affiliation_strings":["Medical Oncology, Merck & Co., Inc., Rahway, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Merck & Co., Inc., Rahway, United States of America","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. Jing","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125025","display_name":"Kelun Group (China)","ror":"https://ror.org/02jpsw347","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210125025"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. Jing","raw_affiliation_strings":["Medical Oncology, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., Chengdu, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., Chengdu, China","institution_ids":["https://openalex.org/I4210125025"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020935848","display_name":"Yingying Shen","orcid":"https://orcid.org/0000-0001-8492-0848","observed_orcids":["https://orcid.org/0000-0001-8492-0848"]},"institutions":[{"id":"https://openalex.org/I4210125025","display_name":"Kelun Group (China)","ror":"https://ror.org/02jpsw347","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210125025"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Y. Shen","raw_affiliation_strings":["Medical Oncology, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., Chengdu, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., Chengdu, China","institution_ids":["https://openalex.org/I4210125025"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Ge","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125025","display_name":"Kelun Group (China)","ror":"https://ror.org/02jpsw347","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210125025"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Ge","raw_affiliation_strings":["Medical Oncology, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., Chengdu, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., Chengdu, China","institution_ids":["https://openalex.org/I4210125025"]}]},{"author_position":"last","author":{"id":null,"display_name":"L. Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146711","display_name":"Sun Yat-sen University Cancer Center","ror":"https://ror.org/0400g8r85","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210146711"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L. Zhang","raw_affiliation_strings":["Internal Department, Sun Yat-sen University Cancer Center, Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Department, Sun Yat-sen University Cancer Center, Guangzhou, China","institution_ids":["https://openalex.org/I4210146711"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":17,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.3293,"has_fulltext":false,"cited_by_count":1,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.49003501,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"36","issue":null,"first_page":"S1036","last_page":"S1037"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7949000000953674,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7949000000953674,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.19269999861717224,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sacituzumab-tirumotecan","display_name":"sacituzumab tirumotecan","score":0.9670000076293945},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9890000224113464},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.871999979019165},{"id":"https://openalex.org/keywords/pd-l1-positive","display_name":"PD-L1-positive","score":0.7900000214576721},{"id":"https://openalex.org/keywords/trop2","display_name":"TROP2","score":0.6930000185966492},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9509999752044678},{"id":"https://openalex.org/keywords/topoisomerase-i-inhibitor","display_name":"topoisomerase I inhibitor","score":0.9599999785423279},{"id":"https://openalex.org/keywords/pd-1-pd-l1-inhibitors","display_name":"PD-1/PD-L1 inhibitors","score":0.6990000009536743},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8339999914169312},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7609999775886536}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9323999881744385},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7243000268936157},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.387800008058548},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37459999322891235},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.34360000491142273},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3052000105381012},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.295199990272522},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.295199990272522},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.259799987077713},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.22859999537467957}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.annonc.2025.08.2573","doi":"https://doi.org/10.1016/j.annonc.2025.08.2573","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2025.08.2573","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.annonc.2025.08.2573","doi":"https://doi.org/10.1016/j.annonc.2025.08.2573","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2025.08.2573","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332932","display_name":"Merck Sharp and Dohme","ror":"https://ror.org/004nn4n27"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4410802817","https://openalex.org/W7162575778","https://openalex.org/W4403419774","https://openalex.org/W4400037391","https://openalex.org/W7222541155","https://openalex.org/W4413306670","https://openalex.org/W7162754680","https://openalex.org/W4402561339","https://openalex.org/W4409821677","https://openalex.org/W4410815858"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4415940906","counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2025-11-06T00:00:00"}
